A health worker holds a vial with doses of the Oxford-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Paramaribo, Suriname February 23, 2021. REUTERS/Ranu Abhelakh